Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.30 |
| ▸ | CA2 | P00918 | 3/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439285 | 1.00 | ALDH1A1 (0.56) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL14505815 | 1.00 | ALDH1A1 (0.56) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL14778022 | 0.94 | ALDH1A1 (0.60) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL19024347 | 0.87 | ALDH1A1 (0.48) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL575402 | 0.87 | ALDH1A1 (0.48) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL14779634 | 0.84 | ALDH1A1 (0.50) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL2756236 | 0.84 | ALDH1A1 (0.50) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL14778728 | 0.82 | ALDH1A1 (0.48) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL14780210 | 0.82 | ALDH1A1 (0.48) | ALDH1A1USP2TSHRKDM4ELMNA | |
| SCHEMBL2166961 | 0.81 | TSHR (0.48) | ALDH1A1USP2TSHRKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9240614-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-2543662-B1 | PROCESS FOR PREPARATION OF ALKYL METHANESULFONATE SOLUTION | SUMITOMO CHEMICAL CO (JP) | 2015-04-22 | — | — | EP | disclosed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | disclosed |
| EP-2579377-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130071733-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-7807426-B2 | Processes for producing optically active 1-substituted 2-methylpyrrolidine | KANEKA CORPORATION (JP) | 2010-10-05 | — | — | US | disclosed |
| US-20070292926-A1 | Processes for Producing Optically Active 1-Substituted 2-Methylpyrrolidine and Intermediate Therefor | KANEKA CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1715054-A1 | PROCESSES FOR PRODUCING OPTICALLY ACTIVE 1-SUBSTITUTED 2-METHYLPYRROLIDINE AND INTERMEDIATE THEREFOR | KANEKA CORPORATION (JP) | 2006-10-25 | — | — | EP | disclosed |
| US-4251626-A | FOR X-RAY FILMS | FUJI PHOTO FILM CO., LTD. (JP) | 1981-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292926-A1 | Processes for Producing Optically Active 1-Substituted 2-Methylpyrrolidine and Intermediate Therefor | FAR1, NOTUM, ALDH7A1 | ALDH1A1 75/4885USP2 2226/4885TSHR 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.